Jazz Pharmaceuticals plc

XNAS:JAZZ   4:00:00 PM EDT
229.55
+0.78 (+0.34%)
4:10:04 PM EDT: $229.55 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)14.40B
Current PE488.34
Forward PE 9.14
2yr Forward PE 8.95
See more stats
Estimates Current Quarter
Revenue$1.11 Billion
Adjusted EPS$6.12
See more estimates
10-Day MA$224.81
50-Day MA$198.93
200-Day MA$162.09
See more pivots

Jazz Pharmaceuticals plc Stock, XNAS:JAZZ

Waterloo Exchange, Waterloo Road, Dublin, Dublin 4
Ireland
Phone: +353.1.634.7800
Number of Employees: 2800
http://www.jazzpharmaceuticals.com

Description

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.